Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
62 studies found for:    "Prader-Willi syndrome"
Show Display Options
Rank Status Study
21 Completed Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome;   Obesity
Intervention:
22 Completed Plasma Adiponectin Level and Vascular Endothelial and Smooth Muscle Cell Function in Children With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome;   Obesity
Intervention:
23 Completed Hypoglycemia in Prader-Willi Syndrome
Conditions: Prader Willi Syndrome;   Hypoglycemia
Intervention: Other: Infants with Prader-Willi Syndrome
24 Terminated Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome;   Obesity
Interventions: Drug: ZGN-440 for Injectable Suspension;   Drug: ZGN-440 Placebo for Injectable Suspension
25 Completed Increased Expression of Adiponectin Receptor 2 in the Mononuclear Cells in Children With Prader-Willi Syndrome
Conditions: Obesity;   Prader-Willi Syndrome
Intervention:
26 Completed Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome;   Self-Injurious Behavior
Intervention: Drug: Topiramate
27 Recruiting Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS)
Condition: Confirmed Genetic Diagnosis of Prader-Willi Syndrome
Interventions: Drug: Tesofensine/Metoprolol;   Drug: Placebos
28 Active, not recruiting Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome;   Hyperphagia
Interventions: Drug: Intranasal Oxytocin (IN-OXT);   Drug: Matched Placebo
29 Terminated Prader-Willi Syndrome and Appetite
Conditions: Hyperphagia;   Prader-Willi Syndrome
Intervention: Drug: Sandostatin LAR
30 Completed Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?
Conditions: Prader-Willi Syndrome;   Growth Hormone Deficiency
Interventions: Drug: Growth hormone (Genotonorm® or Omnitrope®);   Procedure: DEXA, blood tests, H.G.P.O, osseous age.;   Procedure: biopsy
31 Unknown  Exploring Stress and Coping Behaviors of the Major Carer Whose Children With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Interventions: Other: counseling, emotional support;   Other: emotional support
32 Completed Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome
Conditions: Genetic Disorder;   Prader-Willi Syndrome
Intervention: Drug: somatropin
33 Unknown  Family-based Intervention for Youth With Prader-Willi Syndrome: The Active Play at Home Study
Conditions: Prader Willi Syndrome;   Childhood Obesity
Intervention: Behavioral: Active Play at Home
34 Unknown  Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
Conditions: Prader Willi Syndrome;   Adrenal Insufficiency
Interventions: Other: Low dose (1 mcg) ACTH stimulation test;   Other: Overnight metyrapone test
35 Active, not recruiting Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi Syndrome
Conditions: Silver Russell Syndrome;   Prader-Willi Syndrome
Interventions: Drug: Anastrozole;   Drug: Placebo
36 Recruiting Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome
Conditions: Hyperphagia;   Prader-Willi Syndrome
Intervention: Device: tDCS
37 Completed Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity
Conditions: Prader-Willi Syndrome;   Obesity
Interventions: Other: Group 1;   Other: Group 2
38 Completed Ghrelin Suppression by Octreotide in Prader-Willi
Condition: Prader Willis Syndrome
Interventions: Drug: Placebo;   Drug: Octreotide
39 Recruiting PWS European Blood Bank for Infants and Controls From 0 to 48 Months
Condition: Prader-Willi Syndrome
Intervention: Other: blood samples
40 Completed Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
Conditions: Prader Willi Syndrome;   Obsessive-compulsive Disorder
Interventions: Behavioral: Cognitive-behavioral therapy;   Behavioral: Wait-list control

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.